Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases.
Gerber
Peter Arne
PA
Bölke
Edwin
E
Buhren
Bettina Alexandra
BA
Bruch-Gerharz
Daniela
D
Fenk
Roland
R
Reifenberger
Julia
J
Budach
Wilfried
W
Haas
Rainer
R
Homey
Bernhard
B
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003875:Drug Eruptions / Q000209:etiology* / Q000517:prevention & control*; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib